China Oncology ›› 2016, Vol. 26 ›› Issue (10): 813-819.doi: 10.19401/j.cnki.1007-3639.2016.10.002

Previous Articles     Next Articles

miR-26a suppresses gastric cancer cell invasion by targeting MMP16

CHEN Zhiyu1, WANG Chenchen1, HU Jian2, ZHAO Xiaoying1, LI Wenhua1, ZHU Xiaodong1   

  1. 1.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 2.Department of Gastroenterology, the 455th Hospital of Chinese People's Liberation Army, Shanghai 200052, China
  • Online:2016-10-30 Published:2016-11-17
  • Contact: CHEN Zhiyu E-mail: zychan75@163.com

Abstract: Background and purpose: Invasion and metastasis lead to poor prognosis in gastric cancer. In this study, we investigated the potential function of miR-26a in gastric cancer. Methods: Real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the expression of miR-26a in gastric cancer cells. In vitro CCK-8 assay, cloning formation assay and Matrigel-Transwell assay were used to evaluate the proliferation, migration and invasion of gastric cancer cells. A luciferase reporter assay was also conducted to confirm that matrix metalloproteinase-16 (MMP16) is a direct target of miR-26a. Results: miR-26a was down-regulated in gastric cancer tissues compared with that in non-cancerous tissues. Functional studies showed that miR-26a inhibited cell proliferation, colony formation, cell motility and invasion. However, miR-26a had no effect on cell proliferation. We also characterized MMP16 as a direct target of miR-26a. We showed that knocking down MMP16 in gastric cancer cells significantly decreased MMP16 expression and inhibited cell invasion, whereas ectopic MMP16 expression significantly abrogated the suppressed cell invasion induced by miR-26a. Conclusion: miR-26a suppresses gastric cancer cell invasion by targeting MMP16. miR-26a could represent a potential therapeutic target for gastric cancer.

Key words: miR-26a, Gastric cancer, Matrix metalloproteinase-16, Invasion